Research ArticleBasic Science Investigation
Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET
Rafal Swiercz, Srinivas Chiguru, Amir Tahmasbi, Saleh M. Ramezani, Guiyang Hao, Dilip K. Challa, Matthew A. Lewis, Padmakar V. Kulkarni, Xiankai Sun, Raimund J. Ober, Ralph P. Mason and E. Sally Ward
Journal of Nuclear Medicine May 2014, jnumed.113.136481; DOI: https://doi.org/10.2967/jnumed.113.136481
Rafal Swiercz
1Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas
Srinivas Chiguru
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Amir Tahmasbi
3Department of Electrical Engineering, University of Texas at Dallas, Richardson, Texas
Saleh M. Ramezani
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Guiyang Hao
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Dilip K. Challa
1Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas
Matthew A. Lewis
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Padmakar V. Kulkarni
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Xiankai Sun
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
Raimund J. Ober
1Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas
3Department of Electrical Engineering, University of Texas at Dallas, Richardson, Texas
Ralph P. Mason
2Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas; and
E. Sally Ward
1Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET
Rafal Swiercz, Srinivas Chiguru, Amir Tahmasbi, Saleh M. Ramezani, Guiyang Hao, Dilip K. Challa, Matthew A. Lewis, Padmakar V. Kulkarni, Xiankai Sun, Raimund J. Ober, Ralph P. Mason, E. Sally Ward
Journal of Nuclear Medicine May 2014, jnumed.113.136481; DOI: 10.2967/jnumed.113.136481
Use of Fc-Engineered Antibodies as Clearing Agents to Increase Contrast During PET
Rafal Swiercz, Srinivas Chiguru, Amir Tahmasbi, Saleh M. Ramezani, Guiyang Hao, Dilip K. Challa, Matthew A. Lewis, Padmakar V. Kulkarni, Xiankai Sun, Raimund J. Ober, Ralph P. Mason, E. Sally Ward
Journal of Nuclear Medicine May 2014, jnumed.113.136481; DOI: 10.2967/jnumed.113.136481